Alvotech
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Its last 3 Sell calls were followed by roughly flat moves (-2%) three months out.
- Recent price momentum is -11.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 1.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 14:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 19.9x | Better than 38% |
| Price / Sales | 3.0x | Better than 42% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 59.8% | Better than 74% |
| Operating margin | 13.3% | Better than 61% |
| Net margin | 4.8% | Better than 43% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -7.0% | Better than 57% |
| 6-month return | 23.4% | Better than 85% |
| 12-month return (ex latest month) | -6.8% | Better than 25% |
| Distance below 52-week high | 36.9% | Better than 32% |
Financial Health D
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.9x | Better than 53% |
| Debt to assets | 97.4% | Better than 1% |
| Interest coverage | 2.0x | Better than 36% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 94.2% | Better than 82% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 4.29
- Open
- 4.26
- Day range
- 4.09 - 4.29
- Avg price
- 4.17
- Volume
- 826.67K
- Turnover
- 3.45M
- Turnover ratei
- 0.68%
- Volume ratioi
- 0.60
- Amplitudei
- 4.66%
- 52-week rangei
- 2.94 - 6.53
Valuation
- P/Ei
- 41.20
- P/E (TTM)i
- -5.02
- P/Bi
- -5.50
- EPSi
- 0.10
- Book value / shi
- -0.75
- Net profit
- 35.68M
- Net assets
- -267.26M
Share structure
- Market cap
- 1.47B
- Float capi
- 498.39M
- Shares out
- 356.82M
- Float sharesi
- 120.97M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-11-09
36.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.29M net over the window
Short interest
- Shares short
- 6.18M
- % of floati
- 1.73%
- Days to coveri
- 8.26
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Alvotech (ALVO)?
Alvotech last traded at 4.12. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Alvotech's market cap?
About 1.47B.
What is the P/E ratio of Alvotech?
The trailing twelve-month P/E is -5.02, below its own 5-year average of 1.00 — in the middle of its historical range (49.60% percentile). See the Valuation tab for the full history.
Does Alvotech pay a dividend?
Alvotech does not currently pay a regular dividend.
Is Alvotech a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 8.00, which implies 94.2% upside from the current price. This is not investment advice.
What is Alvotech's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Alvotech a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Alvotech discussion 0 comments